SLC17A1 encodes a sodium-dependent phosphate transporter crucial for renal phosphate resorption and urate transport. The protein functions as a symporter at the apical plasma membrane of renal proximal tubule cells, mediating active phosphate uptake via sodium cotransport. Recent evidence extends SLC17A1's physiologic roles to include renal excretion of N-lactoyl-phenylalanine (Lac-Phe), a lactate-derived metabolite that suppresses appetite 1. Genetic variation in SLC17A1 significantly influences serum urate levels and gout risk. Loss-of-function mutations impair renal urate excretion, promoting hyperuricemia, while gain-of-function variants like I269T increase urate export and reduce gout susceptibility 2. Common polymorphisms (rs1165196, rs3757131) associate with altered cholesterol homeostasis and elevated homocysteine in Japanese men 3. The rs2096386 variant shows positive interaction with alcohol consumption in predisposing to hyperuricemia among Uygur patients 4. Genome-wide association studies implicate SLC17A1 in phthalate metabolite excretion, with bioinformatics supporting a causal role in MECPP and MEHHP renal clearance 5. Rare nonsynonymous variants such as p.W75C reduce urate transport function in vitro 6. Emerging linkage evidence suggests potential involvement in type 1 diabetes pathogenesis in Kuwaiti families 7, though mechanistic details remain unclear.